Find Federal Grants
AmeriCorps · AC-12-13-24
AmeriCorps · AC-12-12-24
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
National Institutes of Health · RFA-NR-25-003
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-154
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-346
U.S. Mission to Mauritius · PORTLOUIS-AEIF-FY25-01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-321
U.S. Mission to Georgia · PDS-DOS-GEO-FY25-003
Bureau of Human Resources · DFOP0017022
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institutes of Health · PAR-25-100
National Institutes of Health · PAR-24-330
National Institutes of Health · RFA-HG-25-007
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-298
National Energy Technology Laboratory · DE-FOA-0003497
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
National Institutes of Health · PAR-24-319
DOC NOAA - ERA Production · NOAA-OAR-SG-2026-29505
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
National Institutes of Health · PAR-25-299
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-26-056
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-26-055
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
National Institutes of Health · PAR-25-242